Cargando…
Editorial: TNFRSF agonists: mode of action and therapeutic opportunities
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660652/ https://www.ncbi.nlm.nih.gov/pubmed/38022660 http://dx.doi.org/10.3389/fimmu.2023.1328100 |
| _version_ | 1785137801926279168 |
|---|---|
| author | Obermajer, Nataša Zwolak, Adam Wajant, Harald |
| author_facet | Obermajer, Nataša Zwolak, Adam Wajant, Harald |
| author_sort | Obermajer, Nataša |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10660652 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-106606522023-01-01 Editorial: TNFRSF agonists: mode of action and therapeutic opportunities Obermajer, Nataša Zwolak, Adam Wajant, Harald Front Immunol Immunology Frontiers Media S.A. 2023-11-07 /pmc/articles/PMC10660652/ /pubmed/38022660 http://dx.doi.org/10.3389/fimmu.2023.1328100 Text en Copyright © 2023 Obermajer, Zwolak and Wajant https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Immunology Obermajer, Nataša Zwolak, Adam Wajant, Harald Editorial: TNFRSF agonists: mode of action and therapeutic opportunities |
| title | Editorial: TNFRSF agonists: mode of action and therapeutic opportunities |
| title_full | Editorial: TNFRSF agonists: mode of action and therapeutic opportunities |
| title_fullStr | Editorial: TNFRSF agonists: mode of action and therapeutic opportunities |
| title_full_unstemmed | Editorial: TNFRSF agonists: mode of action and therapeutic opportunities |
| title_short | Editorial: TNFRSF agonists: mode of action and therapeutic opportunities |
| title_sort | editorial: tnfrsf agonists: mode of action and therapeutic opportunities |
| topic | Immunology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660652/ https://www.ncbi.nlm.nih.gov/pubmed/38022660 http://dx.doi.org/10.3389/fimmu.2023.1328100 |
| work_keys_str_mv | AT obermajernatasa editorialtnfrsfagonistsmodeofactionandtherapeuticopportunities AT zwolakadam editorialtnfrsfagonistsmodeofactionandtherapeuticopportunities AT wajantharald editorialtnfrsfagonistsmodeofactionandtherapeuticopportunities |